A randomized, double blind, multi-centered, placebo controlled study of Simvastatin in the treatment of idiopathic chronic pancreatitis - SIP Study

SIDS Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•At screening, Adult patients ( >18 years of age, at the time of enrollment) with chronic pancreatitis (Cambridge grade 0 to III); and women of child-bearing potential having confirmed negative pregnancy test result prior to enrollment are eligible for the study.

•1. If the patients had major ductal abnormalities (Cambridge Grade IV) or complications of chronic pancreatitis
•2. If there will be any evidence of complete pancreas divisum either by MRCP or ERCP.
•3. If there will be a history of active malignancy or pancreatic surgery or chronic myopathy
•4. If patients were narcotic dependent or had previous exposure to HMG CoA inhibitor therapy
•5. If the patient had family history of pancreatitis or pancreatic cancer
•6. Pregnant or breast feeding women
•7. If patient had any other reversible etiology such as alcohol, smoking, hypertriglyceridemia, autoimmune pancreatitis

发起方

SIDS Hospital and Research Centre